Molecular Features of the Measles Virus Viral Fusion Complex That Favor Infection and Spread in the Brain
Author(s) -
Cyrille Mathieu,
Francesca T. Bovier,
Marion Ferren,
Nicole A. P. Lieberman,
Camilla Predella,
Alexandre Lalande,
Vikas Peddu,
Michelle J. Lin,
Amin Addetia,
Achchhe Patel,
Victor K. Outlaw,
Barbara Corneo,
N. Valerio Dorrello,
Thomas Briese,
Diana Hardie,
Branka Horvat,
Anne Moscona,
Alexander L. Greninger,
Matteo Porotto
Publication year - 2021
Publication title -
mbio
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.562
H-Index - 121
eISSN - 2161-2129
pISSN - 2150-7511
DOI - 10.1128/mbio.00799-21
Subject(s) - measles virus , subacute sclerosing panencephalitis , virology , biology , virus , encephalitis , immune system , oncolytic virus , fusion protein , measles , immunology , vaccination , genetics , gene , recombinant dna
Measles virus (MeV) bearing a single amino acid change in the fusion protein (F)—L454W—was isolated from two patients who died of MeV central nervous system (CNS) infection. This mutation in F confers an advantage over wild-type virus in the CNS, contributing to disease in these patients. Using murine ex vivo organotypic brain cultures and human induced pluripotent stem cell-derived brain organoids, we show that CNS adaptive mutations in F enhance the spread of virus ex vivo . The spread of virus in human brain organoids is blocked by an inhibitory peptide that targets F, confirming that dissemination in the brain tissue is attributable to F. A single mutation in MeV F thus alters the fusion complex to render MeV more neuropathogenic.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom